The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Novo Nordisk has teamed up on a project that rewards diabetes patients with lower copays if they stick with their meds.

Merck has a big target in mind for its pneumococcal vaccine V114: Prevnar 13, the world's best-selling shot—and its phase 3 program shows it.

Eli Lilly’s first oncology campaign launched last week, putting the drugmaker on a growing list of pharma companies running DTC ads for cancer drugs.

It’s been a strange road for BMS' Opdivo-Yervoy combo in first-line kidney cancer, but the New Jersey drugmaker finally has a go-ahead.

Merck needed a big win in melanoma to help it try to catch up to archrival Bristol-Myers Squibb. And over the weekend, it got one.

While consumers are all abuzz about the Facebook data scandal, pharma companies don't need to scramble. Just keep an eye open.

​​​​​​​Thermo Fisher features its employees and the patients they help in a new campaign that personalizes its drug development and delivery services.